Kezar and Xeris file for IPOs, join­ing May's march to the pub­lic mar­kets

Adding to the flur­ry of IPOs be­fore May wraps up, two more biotechs filed in­ten­tions Thurs­day to go pub­lic: San Fran­cis­co’s Kezar Life Sci­ences hopes to raise $80.5 mil­lion, while Chica­go’s Xeris Phar­ma­ceu­ti­cals is shoot­ing for $75 mil­lion.

Both com­pa­nies plan to list on the Nas­daq, join­ing about a dozen oth­er biotechs that have trot­ted out to the pub­lic mar­kets this month. Just yes­ter­day, we saw Ma­gen­ta Ther­a­peu­tics, Kiniksa, Schol­ar Rock, and Aptinyx all file or wrap IPOs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER